Phase 4Completed
The Efficacy and Tolerability of Acarbose in Healthy Individuals
The Efficacy and Tolerability of Acarbose in Healthy Individuals: A Prospective Trial for Acarbose in Healthy Individuals Assessing Safety and Efficacy in Reducing Glucose Spikes After Carbohydrate Consumption.
- Sponsor
- AgelessRx (Industry)
- Enrolment
- 15 enrolled
- Conditions
- Tolerance; Side Effect; Glucose Response
- Interventions
- Acarbose Tablets 50mg
- Ages
- adults, older adults
- Registry
- NCT05542849
From the registry
A Prospective Trial for Acarbose in Healthy Individuals Assessing Safety and Efficacy in Reducing Glucose Spikes After Carbohydrate Consumption.
Primary outcomes
- Monophasic glucose response